A multi-glycoprotein synergized recombinant virus system resolves the research dilemma of Epstein-Barr virus entry and facilitates the development of entry-specific drugs or vaccines

 Highlights

  • •
    A novel virus system rEBV-VSV was developed realizing efficient and native EBV entry via multi-synergetic glycoproteins with sensitive bioluminescence detection.
  • •
    rEBV-VSV was especially competent for rapid and high-throughput entry-inhibition evaluation of drugs, antibodies, or sera and accurate study of EBV entry mechanisms via flexible mutations or recombination on rEBV-VSV.
  • •
    Glycoprotein 42 (gp42) was found to mediate diverse functions of an important mutation L65A+L69A on glycoprotein H (gH) and also manipulated the efficacy of gH-targeted antibodies.

Abstract

Epstein-Barr virus (EBV) causes multiple severe diseases, and its entry process is a promising prophylactic and therapeutic target. However, EBV entry is intricate with several unresolved mechanisms, and current research methods for it is limited, insensitive, and inefficient. Therefore, novels methods are urgently needed. Herein, we innovatively reported a recombinant virus system rEBV-VSV realizing complicated multi-glycoprotein synergized EBV entry with sensitive detection, which was especially suitable for accurate study of entry mechanisms and effective evaluation of entry-inhibitive therapies. First, rEBV-VSV efficiently entered host cells via multi-synergetic EBV glycoproteins on its membrane and simulated entry features and cellular tropisms of native EBV, also being sensitively detected via bioluminescence. Second, rEBV-VSV was an effective measuring system to evaluate entry-inhibiting potency of EBV-specific antibodies and population’s sera in a rapid and high-throughput manner. Third, via flexible mutations and recombination on rEBV-VSV, it was used to accurately study functions of glycoproteins and key residues during EBV entry to better understand entry mechanisms. Especially, via rEBV-VSV, glycoprotein H (gH) mutation L65A+L69A was found to have completely opposite effects on EBV entry into B and epithelia cells, which was manipulated by gp42, and gp42 also powerfully impacted the efficacy of gH-specific antibody E1D1. Conclusively, rEBV-VSV was a satisfactory system to study EBV entry features, mechanisms, and entry-targeted therapies, which could resolve the research dilemma of EBV entry and facilitate the development of EBV-specific drugs and vaccines.

Read full article for free (open access):
https://www.sciencedirect.com/science/article/pii/S2666517426000271



Popular posts from this blog

Salivary microbiome diversity is associated with oral health and disease

Image
The oral microbiome is a complex community of bacteria, fungi, and viruses that inhabit the oral cavity. Microbes of the oral microbiome are implicated in health and disease. We collected 220 unstimulated saliva samples from patients with periodontal disease and varying degrees of dental caries, as well as from subjects with no signs of oral disease. Metagenomic analysis of saliva revealed significantly higher abundance of periodontal pathogens in people with gum disease, and significantly higher abundance of cariogenic species in people with dental caries. We also found that salivary microbiome diversity was significantly higher in people with periodontal disease, but not in those with only caries. Furthermore, oral microbiome diversity is affected by oral hygiene habits such as flossing frequency, but not brushing frequency. Clustering and differential analysis allowed us to identify specific commensal species, such as  Prevotella pallens and Veillonella atypica , which are signi...
Read more